Innovent Biologics, Inc.

1801.HK · Moat type: REGULIERUNG

MoatScore

4/10

Fair Value

18 HKD (≈ 2.26 USD)

Margin of Safety

-446.8 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Innovent Biologics develops, manufactures, and commercializes biopharmaceutical products – primarily monoclonal antibodies and innovative therapeutics for oncology, autoimmune diseases, and metabolic disorders – and generates revenues through drug sales in China as well as from licensing and collaboration agreements with global partners.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.